Astex Pharmaceuticals (ASTX) jumps 4% before the bell after saying treatment with the...

|About: Astex Pharmaceuticals, Inc. (ASTX)|By:, SA News Editor

Astex Pharmaceuticals (ASTX) jumps 4% before the bell after saying treatment with the hypomethylating agent, SGI-110 produced an overall clinical response rate of 40% in patients with heavily pre-treated myelodysplastic syndrome (preleukemia). (PR)